For example, in triple adverse breast cancer (TNBC),25 and in hepatocellular carcinoma,26 DNA methylation profiles have helped for the identification of distinct subgroups with clinical relevance. Epigenetic strategies have also served to the development of prognostic checks to evaluate the sensitivity of cancer cells to particular medicines.27 Even though https://directivepublications.org/world-journal-of-clinical-cancer-research/